![]() |
Weight-loss injectables like Wegovy or Ozempic are gaining popularity amid an escalating global obesity crisis. Since 1975, worldwide obesity rates have nearly tripled, with projections indicating that over half of the global population will be overweight or obese by 2035. John Schoonbee, Global Chief Medical Officer, and Adam Strange, Life & Health R&D Manager, elaborate on the impact of GLP-1 drugs on weight loss, metabolic health and insurance. These medications influence risk factors such as insulin resistance, cardiovascular disease, and cancer. Additionally, they discuss the implications of these drugs on Life & Health insurance, including life, critical illness, and disability income, as well as future underwriting risk assessments. |
|
|
|
|
Senior Portfolio Analyst | ||
London - £70,000 Per Annum |
Reserving Actuary | ||
London - £100,000 Per Annum |
Senior Pricing Actuary - Personal Lines | ||
London - £130,000 Per Annum |
Senior Manager | ||
London - £150,000 Per Annum |
Pricing Actuary - Longevity Swaps | ||
London/hybrid 2-3dpw office-based - Negotiable |
Senior Reinsurance Pricing Actuary | ||
London - £200,000 Per Annum |
London Market Reserving Actuary | ||
London / 4dpw office-based - Negotiable |
GI Senior Actuarial Consultant - Inte... | ||
Zurich - Negotiable |
P&C Senior Manager | ||
London - Negotiable |
Senior Reserving Analyst | ||
London / hybrid 3 dpw office-based - Negotiable |
Deputy Head of Pricing | ||
London - £150,000 Per Annum |
BPA Implementation Analyst | ||
North-West / hybrid 2-3dpw office-based - Negotiable |
Pricing Actuary – London Market | ||
London / Hybrid - Negotiable |
Pricing & Underwriting Analyst | ||
London / Hybrid - Negotiable |
BPA Transition Manager | ||
South East - Negotiable |
Modelling Actuary - Life | ||
South East - Negotiable |
Reporting Actuary - Life | ||
South East - Negotiable |
London Market Pricing Manager | ||
London - Negotiable |
London Market Pricing - FTC | ||
London - Negotiable |
Senior Pensions Data Technician - Ful... | ||
Fully remote - Negotiable |
Be the first to contribute to our definitive actuarial reference forum. Built by actuaries for actuaries.